These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 21998480

  • 1. Time to refocus on HSV interventions for HIV prevention?
    Tanton C, Abu-Raddad LJ, Weiss HA.
    J Infect Dis; 2011 Dec 15; 204(12):1822-6. PubMed ID: 21998480
    [No Abstract] [Full Text] [Related]

  • 2. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
    Mugwanya K, Baeten JM, Mugo NR, Irungu E, Ngure K, Celum C.
    J Infect Dis; 2011 Dec 15; 204(12):1912-7. PubMed ID: 21998479
    [Abstract] [Full Text] [Related]

  • 3. Herpes treatment may limit HIV transmission and progression.
    Wilkinson E.
    Lancet Infect Dis; 2007 Apr 15; 7(4):249. PubMed ID: 17419138
    [No Abstract] [Full Text] [Related]

  • 4. High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.
    Perti T, Saracino M, Baeten JM, Johnston C, Diem K, Ocbamichael N, Huang ML, Selke S, Magaret A, Corey L, Wald A.
    J Acquir Immune Defic Syndr; 2013 Jun 01; 63(2):201-8. PubMed ID: 23542637
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C.
    J Infect Dis; 2007 Nov 15; 196(10):1500-8. PubMed ID: 18008230
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of antiviral drugs to prevent herpesvirus transmission.
    Crumpacker CS.
    N Engl J Med; 2004 Jan 01; 350(1):67-8. PubMed ID: 14702430
    [No Abstract] [Full Text] [Related]

  • 9. Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
    Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N, Sanchez J, Essex M, Makhema J, Kiarie J, Farquhar C, Corey L.
    J Infect Dis; 2011 Jan 01; 203(1):117-21. PubMed ID: 21148504
    [Abstract] [Full Text] [Related]

  • 10. HSV therapy and HIV-1 reduction.
    Martinez V, Caumes E.
    N Engl J Med; 2007 May 31; 356(22):2323; author reply 2324. PubMed ID: 17538093
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
    Roxby AC, Drake AL, Ongecha-Owuor F, Kiarie JN, Richardson B, Matemo DN, Overbaugh J, Emery S, John-Stewart GC, Wald A, Farquhar C.
    PLoS One; 2012 May 31; 7(6):e38622. PubMed ID: 22701683
    [Abstract] [Full Text] [Related]

  • 14. The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.
    Van Wagoner N, Geisler WM, Bachmann LH, Hook EW.
    Int J STD AIDS; 2015 Jul 31; 26(8):574-81. PubMed ID: 25147236
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HSV-2 suppression reduces HIV and HSV shedding.
    Collins S.
    GMHC Treat Issues; 2005 Dec 31; 19(12):11. PubMed ID: 16909510
    [No Abstract] [Full Text] [Related]

  • 17. Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir.
    Roxby AC, Liu AY, Drake AL, Kiarie JN, Richardson B, Lohman-Payne BL, John-Stewart GC, Wald A, De Rosa S, Farquhar C.
    AIDS Res Hum Retroviruses; 2013 Jan 31; 29(1):94-8. PubMed ID: 22852760
    [Abstract] [Full Text] [Related]

  • 18. Trial shows HSV-2 suppression can reduce HIV shedding.
    IAVI Rep; 2006 Jan 31; 10(1):20. PubMed ID: 16628770
    [No Abstract] [Full Text] [Related]

  • 19. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L.
    J Infect Dis; 2002 Dec 15; 186(12):1718-25. PubMed ID: 12447756
    [Abstract] [Full Text] [Related]

  • 20. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK, Baker D, Snowden W.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.